Ambu A/s Class B · OMXCOP:AMBU_B

Ambu A/s Class B — Q2 2010/11 Earnings Presentation

19 slides from Ambu A/s Class B's earnings presentation, 2011

1. Slide 1: Interim Report Q2 2010/11

   INTERIM REPORT Q2 2010/11 BY CEO LARS MARCHER AND CFO ANDERS ARVAI 1

2. Slide 2: Agenda

   AGENDA ƒ Developments in Q2 2010/11 ƒ Status of GPS Four ƒ Outlook 2010/11 2

3. Slide 3: Highlights Q2 2010/11

   HIGHLIGHTS Q2 2010/11 ƒ Growth in revenue above market growth – strong growth in revenue in all regions and double-digit growth rates in the USA and Asia 16% ƒ Improved earnings before special items growth in ƒ Markedly improved cash flow 8% operating profit before non-recurring ƒ Rising prices of r

4. Slide 4: Highlights H1 2010/11

   HIGHLIGHTS H1 2010/11 ƒ Markedly improved earnings ƒ Continued strong growth in revenue, including significant growth in the USA 25% growth in ƒ ƒ Improved free cash flow Implementation of GPS Four strategy 7% operating profit before special growth in items is progressing according to plan revenue D

5. Slide 5: Satisfactory Increase in Revenue

   SATISFACTORY INCREASE IN REVENUE Development in revenue, DKKm ƒ Revenue of DKK 256m in Q2 – up 9% when measured in DKK and 8% when measured in local currencies. Revenue of DKK 489m in H1 – up 9% and 7% when measured in local currencies ƒ Growth higher than estimated market growth – Ambu has won mark

6. Slide 6: Developments within Business Areas

   DEVELOPMENTS WITHIN BUSINESS AREAS Airway Management, DKKm ƒ Growth in revenue of 3% and 2% in Q2 when measured in local currencies ƒ Growth in revenue of 9% and 6% in H1 when measured in local currencies ƒ General market growth of 0-3% ƒ Generally satisfactory growth within laryngeal masks and aSco

7. Slide 7: Operating Profit

   OPERATING PROFIT EBIT before special items, DKKm ƒ EBIT before non-recurring expenses for an employee share scheme and before special items amounted to DKK 39m in Q2 against DKK 34m in Q2 2009/10, up 16% ƒ EBIT before special items amounted to DKK 66m in H1 against DKK 53m in H1 2009/10, up 25% ƒ No

8. Slide 8: Cash Flow

   CASH FLOW DKKm H1 2009/10 H1 2010/11 Cash flow from operating activities 21.6 38.8 Cash flow from investing activities (37.0) (12.8) Free cash flow (15.4) 26.0 Cash flow from financing activities 32.7 (18.3) ƒ Cash flow from operating activities improved due to less funds tied up in working capital

9. Slide 9: Concluded Patent Cases

   CONCLUDED PATENT CASES USA and Europe ƒ Global settlement reached, and all previous pending lawsuits have been concluded ƒ Both parties will make cash payments to the other party ƒ The parties will pay their own legal fees ƒ Total impact of the settlement, including legal fees, after Ambu’s payment

10. Slide 10: GPS Four: Status of Ambu's Business Strategy

    GPS FOUR STATUS OF AMBU’S BUSINESS STRATEGY 10

11. Slide 11: Heading for a Stronger Ambu: Four GPS Coordinates

    HEADING FOR A STRONGER AMBU FOUR GPS COORDINATES Targets 2013 GPS1 INNOVATION Global market-leader within innovative single-use products for hospitals and rescue services GPS2 MARKETS AND SALES Significantly higher revenue GPS3 EFFICIENCY Increasing EBIT margin of up to 15% Efficient operations and

12. Slide 12: GPS1 Innovation

    GPS1 INNOVATION ƒ Global development procedures have been introduced following implementation of a global innovation organisation Ambu’s global innovation ƒ In addition to innovation tasks, focus is on cost organisation is now in place, which price reduction projects for existing products will pave

13. Slide 13: GPS2 Markets and Sales

    GPS2 MARKETS AND SALES ƒ Continued positive effect of the expansion of the sales force in the USA Ambu’s position in the USA continues ƒ Strengthening of Ambu’s sales will focus on to strengthen, and at the same time emerging markets there is considerable potential for ƒ Current activities in Brazil

14. Slide 14: GPS3 Efficiency

    GPS3 EFFICIENCY ƒ The last phase of the transfer of production is planned and completed in Q4 2010/11 With the planned transfer of ƒ Gathering of all Danish activities in one location – production in 2010/11, all Ambu’s in Ballerup production takes place outside ƒ Work is going into optimising inven

15. Slide 15: GPS4 Acquisitions

    GPS4 ACQUISITIONS ƒ Primary focus on activities which can strengthen the company’s position within the hospital Growth via acquisitions is high on sector. Ambu’s agenda, and Ambu sees ƒ Several acquisition opportunities identified – attractive potential for both both as regards product areas and com

16. Slide 16: Updated Outlook for 2010/11

    UPDATED OUTLOOK FOR 2010/11 2010/11 Comments Revenue In the region of DKK Unchanged relative to previously announced 1,000m outlook. Based on an average USD rate of 520 in H2 2010/11, previously based on an average rate of 540 for FY 2010/11 EBIT margin before special items, Approx. 14% Adjusted upw

17. Slide 17: Good Starting Point for Further Growth

    GOOD STARTING POINT FOR FURTHER GROWTH Additional sales of new products ƒ The goal is for sales of new products to account for 10% in 2010/11 ƒ Penetration with aScope and other products ƒ Launch of additional products in 2010/11 Increased activity in emerging markets ƒ Experience and results so far

18. Slide 18: Questions

    QUESTIONS 18

19. Slide 19: Read more at www.ambu.com

    READ MORE AT WWW.AMBU.COM For further information, please contact: Lars Marcher, CEO, lm@ambu.com or +45 5136 2490 Anders Arvai, CFO, aa@ambu.com or +45 7225 2000 19

Ambu — Q2 2010/11 Earnings Presentation on 6ix